{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:08:44Z","timestamp":1780582124067,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HV20C0070"],"award-info":[{"award-number":["HV20C0070"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018M3A9H4079358"],"award-info":[{"award-number":["2018M3A9H4079358"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nano.2021.102438","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T11:07:10Z","timestamp":1625915230000},"page":"102438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform"],"prefix":"10.1016","volume":"37","author":[{"given":"Jongkwan","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheol","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonil","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Jeung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo Han","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Uk","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baik L.","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2021.102438_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"R&D blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nano.2021.102438_bb0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.nano.2021.102438_bb0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit vaccines against emerging pathogenic human coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nano.2021.102438_bb0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2021.102438_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus-like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin Immunol"},{"key":"10.1016\/j.nano.2021.102438_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2021.102438_bb0035","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1016\/j.vaccine.2014.05.064","article-title":"Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin((R))","volume":"32","author":"Zhang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2021.102438_bb0040","doi-asserted-by":"crossref","first-page":"18631","DOI":"10.1038\/s41598-019-54928-y","article-title":"Adeno-associated virus capsid protein expression in Escherichia coli and chemically defined capsid assembly","volume":"9","author":"Le","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2021.102438_bb0045","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nbt1261","article-title":"Vaccine manufacturing: challenges and solutions","volume":"24","author":"Ulmer","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2021.102438_bb0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12275-017-7058-3","article-title":"Exploiting virus-like particles as innovative vaccines against emerging viral infections","volume":"55","author":"Jeong","year":"2017","journal-title":"J Microbiol"},{"key":"10.1016\/j.nano.2021.102438_bb0055","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.nano.2021.102438_bb0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/acs.accounts.6b00514","article-title":"Bacterioferritin: structure, dynamics, and protein-protein interactions at play in iron storage and mobilization","volume":"50","author":"Rivera","year":"2017","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.nano.2021.102438_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/bj1970171","article-title":"The composition and the structure of bacterioferritin of Escherichia coli","volume":"197","author":"Yariv","year":"1981","journal-title":"Biochem J"},{"key":"10.1016\/j.nano.2021.102438_bb0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nano.2012.11.001","article-title":"Development of a nanoparticle-based influenza vaccine using the PRINT technology","volume":"9","author":"Galloway","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2021.102438_bb0075","first-page":"126794","article-title":"A novel vaccine using nanoparticle platform to present immunogenic M2e against avian influenza infection","volume":"2011","author":"Babapoor","year":"2011","journal-title":"Influenza Res Treat"},{"key":"10.1016\/j.nano.2021.102438_bb0080","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.nano.2018.08.010","article-title":"The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses","volume":"14","author":"Bolduc","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2021.102438_bb0085","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2021.102438_bb0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.nano.2021.102438_bb0095","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1016\/j.vaccine.2014.09.030","article-title":"An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization","volume":"32","author":"Raghunandan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2021.102438_bb0100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.vaccine.2012.11.009","article-title":"Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine","volume":"31","author":"Glenn","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2021.102438_bb0105","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S1473-3099(16)00153-5","article-title":"Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997-2015: a systematic review of individual case data","volume":"16","author":"Lai","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nano.2021.102438_bb0110","first-page":"1","article-title":"Egg-independent influenza vaccines and vaccine candidates","volume":"5","author":"Manini","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.nano.2021.102438_bb0115","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3389\/fmicb.2019.02031","article-title":"Soluble recombinant hemagglutinin protein of H1N1pdm09 influenza virus elicits cross-protection against a lethal H5N1 challenge in mice","volume":"10","author":"Yamada","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nano.2021.102438_bb0120","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.vaccine.2005.11.005","article-title":"Expression and purification of an influenza hemagglutinin\u2014one step closer to a recombinant protein-based influenza vaccine","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2021.102438_bb0125","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2021.102438_bb0130","doi-asserted-by":"crossref","first-page":"11822","DOI":"10.1128\/JVI.00891-10","article-title":"Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages","volume":"84","author":"Prabakaran","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2021.102438_bb0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/bit.26810","article-title":"Glycan-masking hemagglutinin antigens from stable CHO cell clones for H5N1 avian influenza vaccine development","volume":"116","author":"Chen","year":"2019","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nano.2021.102438_bb0140","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1128\/JVI.02107-10","article-title":"Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets","volume":"85","author":"Khurana","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2021.102438_bb0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/138920110791111942","article-title":"Expression and refolding technologies for production of recombinant proteins","volume":"11","author":"Arakawa","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.nano.2021.102438_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/btpr.69","article-title":"Production of recombinant HIV-1 nef protein using different expression host systems: a techno-economical comparison","volume":"25","author":"Vermasvuori","year":"2009","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.nano.2021.102438_bb0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/biom4010235","article-title":"Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies","volume":"4","author":"Yamaguchi","year":"2014","journal-title":"Biomolecules"},{"key":"10.1016\/j.nano.2021.102438_bb0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/15476286.2020.1801199","article-title":"Chaperna: linking the ancient RNA and protein worlds","volume":"18","author":"Son","year":"2021","journal-title":"Rna Biol"},{"key":"10.1016\/j.nano.2021.102438_bb0165","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1080\/15476286.2015.1096487","article-title":"M1 RNA is important for the in-cell solubility of its cognate C5 protein: Implications for RNA-mediated protein folding","volume":"12","author":"Son","year":"2015","journal-title":"Rna Biol"},{"key":"10.1016\/j.nano.2021.102438_bb0170","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1017\/S0031182018000434","article-title":"Recombinant adenylate kinase 3 from liver fluke Clonorchis sinensis for histochemical analysis and serodiagnosis of clonorchiasis","volume":"145","author":"Kwon","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.nano.2021.102438_bb0175","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1096\/fj.201700747RR","article-title":"Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation","volume":"32","author":"Yang","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.nano.2021.102438_bb0180","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/j.vaccine.2013.05.080","article-title":"Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines","volume":"31","author":"Jang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2021.102438_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19103016","article-title":"Nucleic acid-dependent structural transition of the intrinsically disordered n-terminal appended domain of human Lysyl-tRNA synthetase","volume":"19","author":"Kwon","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2021.102438_bb0190","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1021\/bi00002a023","article-title":"Polyanion-induced alpha-helical structure of a synthetic 23-residue peptide representing the lysine-rich segment of the N-terminal extension of yeast cytoplasmic aspartyl-tRNA synthetase","volume":"34","author":"Agou","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.nano.2021.102438_bb0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2010.03.047","article-title":"The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity","volume":"403","author":"de Vries","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.nano.2021.102438_bb0200","doi-asserted-by":"crossref","first-page":"13868","DOI":"10.1128\/JVI.01955-13","article-title":"Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions","volume":"87","author":"de Vries","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2021.102438_bb0205","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1128\/JVI.01373-09","article-title":"The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model","volume":"83","author":"Song","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2021.102438_bb0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/vim.2016.0003","article-title":"Vaccination with 2014-15 seasonal inactivated influenza vaccine elicits cross-reactive anti-HA antibodies with strong ADCC against antigenically drifted circulating H3N2 virus in humans","volume":"29","author":"Zhong","year":"2016","journal-title":"Viral Immunol"},{"key":"10.1016\/j.nano.2021.102438_bb0215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.antiviral.2017.06.012","article-title":"A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin","volume":"144","author":"Paul","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nano.2021.102438_bb0220","first-page":"1","article-title":"The vestigial esterase domain of haemagglutinin of H5N1 avian influenza A virus: antigenicity and contribution to viral pathogenesis","volume":"6","author":"Zheng","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.nano.2021.102438_bb0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.coviro.2013.05.004","article-title":"Virus-induced humoral immunity: on how B cell responses are initiated","volume":"3","author":"Zabel","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.nano.2021.102438_bb0230","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/BC.2008.064","article-title":"The coming of age of virus-like particle vaccines","volume":"389","author":"Jennings","year":"2008","journal-title":"Biol Chem"},{"key":"10.1016\/j.nano.2021.102438_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.00750-20","article-title":"Comparability of titers of antibodies against seasonal influenza virus strains as determined by hemagglutination inhibition and microneutralization assays","volume":"58","author":"Heeringa","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.nano.2021.102438_bb0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/irv.12333","article-title":"Optimisation of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses","volume":"9","author":"Lin","year":"2015","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.nano.2021.102438_bb0245","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1080\/17460441.2020.1801629","article-title":"Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection","volume":"15","author":"Jang","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.nano.2021.102438_bb0250","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fcimb.2019.00344","article-title":"The quest for a truly universal influenza vaccine","volume":"9","author":"Jang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.nano.2021.102438_bb0255","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","volume":"20","author":"Kanekiyo","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nano.2021.102438_bb0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/rna.6.1.7441","article-title":"RNA-mediated chaperone type for de novo protein folding","volume":"6","author":"Choi","year":"2009","journal-title":"RNA Biol"},{"key":"10.1016\/j.nano.2021.102438_bb0265","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1080\/15476286.2017.1311455","article-title":"The folding competence of HIV-1 Tat mediated by interaction with TAR RNA","volume":"14","author":"Kim","year":"2017","journal-title":"Rna Biol"},{"key":"10.1016\/j.nano.2021.102438_bb0270","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/bit.26879","article-title":"RNA-dependent chaperone (chaperna) as an engineered pro-region for the folding of recombinant microbial transglutaminase","volume":"116","author":"Lee","year":"2019","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nano.2021.102438_bb0275","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/jmbi.1999.2991","article-title":"Themes in RNA-protein recognition","volume":"293","author":"Draper","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nano.2021.102438_bb0280","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/j.jmb.2015.07.002","article-title":"Gradual folding of an off-pathway molten globule detected at the single-molecule level","volume":"427","author":"Lindhoud","year":"2015","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nano.2021.102438_bb0285","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1473-3099(20)30190-0","article-title":"Scientific and ethical basis for social-distancing interventions against COVID-19","volume":"20","author":"Lewnard","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nano.2021.102438_bb0290","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.sbi.2020.10.014","article-title":"A social distancing measure governing the whole proteome","volume":"66","author":"Choi","year":"2020","journal-title":"Curr Opin Struct Biol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:15:27Z","timestamp":1761549327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":58,"alternative-id":["S1549963421000812"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102438","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102438"}}